Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07265791

Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds

Multicenter, Randomized, Subject & Independent Evaluator-blind, Matched Pairs, Active-controlled, Non-inferiority, Pivotal Study to Evaluate the Efficacy and Safety of Injection With JTM104 as Compared to Juvederm® ULTRA PLUS XC in Temporary Correction of Moderate to Severe Nasolabial Folds

Sponsor: Jetema Co., Ltd.

Conditions Nasolabial Folds, Wrinkles

Interventions JTM104 Juvederm® ULTRA PLUS XC

Updated 1 time since 2026 Last updated: Nov 24, 2025 Started: Jan 3, 2026 Primary completion: Jun 30, 2026 Completion: Jan 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Nasolabial Folds, Wrinkles, this trial is actively recruiting participants. The trial is conducted by Jetema Co., Ltd. and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jetema Co., Ltd.

Data source: Jetema Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.